Pneumococcal vaccine to protect more than a million children in Afghanistan from leading child killer

in page functions

Pneumonia accounts for 25% of deaths of children under five in Afghanistan each year

PCV launch Afghanistan 1

Afghanistan President Hamid Karzai, Minister of Public Health Dr. Suraya Dalil and Karin Hulshof, UNICEF Regional Director for South Asia, look on as an infant is vaccinated at the pneumococcal vaccine launch event in Kabul.

Kabul, 7 December 2013 – Afghanistan is to begin vaccinating more than 1.2 million children against pneumococcal disease every year, President Hamid Karzai announced today.

As part of the Government of Afghanistan’s ongoing efforts to improve the health of its children, life-saving pneumococcal conjugate vaccine (PCV) will be given to all infants under one year of age. The children will be protected against pneumococcal disease, the leading cause of pneumonia, which accounts for 25% of deaths in children under five years of age in Afghanistan.

With the support of the GAVI Alliance and its partners WHO and UNICEF, Afghanistan’s Ministry of Public Health will begin introducing PCV into routine immunisation programmes and the vaccine will be available for free at all health facilities across the country.

"Afghanistan is taking a big step towards securing a healthier future for its children," said Dr Seth Berkley, CEO of the GAVI Alliance. "The addition of pneumococcal vaccine to the childhood immunisation package will help protect the lives of the children who represent the country's future."

About 30,000 children under five in Afghanistan die of pneumonia and it is estimated that about 150,000 children are affected by pneumonia each year.

GAVI has received strong support from partners in the Middle East for its work with Afghanistan.

In January 2011, His Highness Sheikh Mohamed Bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, partnered with the Bill & Melinda Gates Foundation to support immunisation programmes in Pakistan and Afghanistan. Of the US$ 100 million pledged (US$ 50 million each), GAVI received US$ 66 million to introduce the pentavalent1 and pneumococcal vaccines in Afghanistan with the aim of reducing child mortality in the country.

“In Afghanistan, a country which is of particular interest to the UAE because of its proximity and its perilous humanitarian and development situation, it is gratifying to note that the UAE contribution has enabled the vaccination of millions of children with both the 5-in-1 pentavalent and pneumococcal vaccines,” said Her Excellency Sheikha Lubna bint Khalid Al Qasimi, Minister of International Cooperation and Development, United Arab Emirates.

GAVI has also received financial contributions from a public campaign launched by Majid Al Futtaim (MAF) Finance2 during the holy month of Ramadan. During the campaign throughout the UAE, MAF Finance committed to donating 1% of all Najm credit card transactions over AED 2,000 to support GAVI’s mission of increasing access to immunisation in the world’s poorest countries. The campaign raised AED 460,000 (US$ 125,000), clearly demonstrating the generosity of the UAE public towards supporting children in need. This support will help GAVI to immunise an estimated 5,000 children.


1 Pentavalent vaccine protects children from five life-threatening diseases, including diphtheria, pertussis (whooping cough), tetanus, hepatitis B, Haemophilus influenzae type B (Hib), which causes meningitis.

2 Majid Al Futtaim Finance provides credit card and prepaid solutions to consumers and businesses in the Middle East and North Africa.

+243,000,000

GAVI support will assist countries to immunise a further 243 million children from 2011 to 2015.

GAVI Alliance

More facts...

close icon

modal window here